Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 23;18(10):e0292928.
doi: 10.1371/journal.pone.0292928. eCollection 2023.

Post-COVID-19 syndrome: Physical capacity, fatigue and quality of life

Affiliations

Post-COVID-19 syndrome: Physical capacity, fatigue and quality of life

Sebastian Beyer et al. PLoS One. .

Erratum in

Abstract

Purpose: Post-Covid-19 syndrome is defined as the persistence of symptoms beyond 3 months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The most common symptoms include reduced exercise tolerance and capacity, fatigue, neurocognitive problems, muscle pain and dyspnea. The aim of our work was to investigate exercise capacity and markers of subjective wellbeing and their independent relation to post-COVID-19 syndrome.

Patients and methods: We examined a total of 69 patients with post-COVID-19 syndrome (23 male/46 female; age 46±12 years; BMI 28.9±6.6 kg/m2) with fatigue and a score ≥22 in the Fatigue Assessment Scale (FAS). We assessed exercise capacity on a cycle ergometer, a 6-minute walk test, the extent of fatigue (FAS), markers of health-related quality of life (SF-36 questionnaire) and mental health (HADS).

Results: On average the Fatigue Assessment Scale was 35.0±7.4 points. Compared with normative values the VO2max/kg was reduced by 8.6±5.8 ml/min/kg (27.7%), the 6MWT by 71±96 m (11.9%), the health-related quality of life physical component score by 15.0±9.0 points (29.9%) and the mental component score by 10.6±12.8 points (20.6%). Subdivided into mild fatigue (FAS score 22-34) and severe fatigue (FAS score ≥35), patients with severe fatigue showed a significant reduction of the 6-minute walk test by 64±165 m (p<0.01) and the health-related quality of life physical component score by 5.8±17.2 points (p = 0.01). In multiple regression analysis age (β = -0.24, p = 0.02), sex (β = 0.22, p = 0.03), mental (β = -0.51, p<0.01) and physical (β = -0.44, p<0.01) health-related quality of life and by trend the 6-minute walk test (β = -0.22, p = 0.07) were associated with the FAS.

Conclusion: Patients with post-COVID-19 syndrome show reduced maximal and submaximal physical performance as well as limitations in quality of life, particularly pronounced in the physical components. These results are essentially influenced by the severity of fatigue and implicating the need for targeted treatments.

PubMed Disclaimer

Conflict of interest statement

NO authors have competing interest.

Figures

Fig 1
Fig 1. Exercise capacity (A: VO2max; B: 6MWT) and pulmonary capacity (C: FEV1; D: FVCex) in relation to the norm values.
Data are individual values with mean ± SD.
Fig 2
Fig 2. Subscales of the HrQoL questionnaire for men and women compared to the norm values.
Fig 3
Fig 3. Exercise capacity (A: VO2max; B: 6MWT) and HrQoL (C: Physical component score; D: Mental component score) divided into mild and severe fatigue based on FAS score.
The framed p-values are given for differences between mild and severe fatigue as analyzed by Student t test for unpaired samples. Data are mean ± SD.

References

    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023. Mar;21(3):133–146. doi: 10.1038/s41579-022-00846-2 - DOI - PMC - PubMed
    1. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022. Apr;22(4):e102–e107. doi: 10.1016/S1473-3099(21)00703-9 - DOI - PMC - PubMed
    1. Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al.. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis 2022. Apr 9;74(7):1191–1198. doi: 10.1093/cid/ciab611 - DOI - PMC - PubMed
    1. Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al.. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran J Med Sci 2021. Nov;46(6):428–436. doi: 10.30476/ijms.2021.92080.2326 - DOI - PMC - PubMed
    1. Townsend L, Dowds J, O’Brien K, Sheill G, Dyer AH, O’Kelly B, et al.. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc 2021. Jun;18(6):997–1003. doi: 10.1513/AnnalsATS.202009-1175OC - DOI - PMC - PubMed

Publication types